T1	Intervention 20 30	amifostine
T2	Intervention 42 77	radiochemotherapy-induced mucositis
T3	Intervention 82 92	xerostomia
T4	Intervention 171 181	amifostine
T5	Intervention 221 238	radiochemotherapy
T6	Intervention 342 367	conventional radiotherapy
T7	Intervention 493 504	carboplatin
T8	Intervention 552 562	Amifostine
T9	Intervention 635 637	RT
T10	Intervention 659 682	primary study end point
T11	Intervention 789 806	radiochemotherapy
T12	Intervention 838 856	treatment duration
T13	Intervention 858 878	hematologic toxicity
T14	Intervention 884 900	clinical outcome
T15	Intervention 1012 1035	treatment interruptions
T16	Intervention 914 932	treatment duration
T17	Intervention 1077 1119	Acute toxicities (mucositis and dysphagia)
T18	Intervention 1218 1235	Grade 2 mucositis
T19	Intervention 1369 1386	Grade 4 mucositis
T20	Intervention 1486 1495	dysphagia
T21	Intervention 1502 1521	months of follow-up
T22	Intervention 1535 1562	patients in the study group
T23	Intervention 1575 1593	Grade 2 xerostomia
T24	Intervention 1684 1691	therapy
T25	Intervention 1812 1826	Cytoprotection
T26	Intervention 1832 1842	amifostine
T27	Intervention 2004 2014	Amifostine
T28	Intervention 2080 2097	radiochemotherapy
T29	Intervention 2150 2160	amifostine
T30	Intervention 2254 2274	Amifostine treatment
T31	Intervention 2294 2302	clinical
